MEI Pharma, Inc. (NASDAQ:MEIP)

CAPS Rating: 1 out of 5

A development stage company, engaged in the clinical development of the anti-cancer drug phenoxodiol.

Recs

0
Player Avatar pchop123 (79.47) Submitted: 2/15/2013 12:40:18 AM : Underperform Start Price: $6.17 MEIP Score: -15.08

rolloercoaster down

Featured Broker Partners


Advertisement